CTSB and neoplasm: Consequently, FRRG-DOX nanoparticles induce a significant cytotoxicity in cathepsin B-overexpressed tumor tissues by releasing toxic DOX molecules, while DOX release is mitigated in cathepsin B-deficient normal tissues to minimize DOX-related side effects.